| Breakdown | Mar 2024 | Mar 2023 | Mar 2023 | Mar 2022 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.62B | 1.44B | 5.17B | 9.44B | 9.09B |
| Gross Profit | -60.47M | 130.79M | 760.81M | 916.73M | 535.24M |
| EBITDA | -2.15B | -323.19M | 414.63M | -9.84M | -203.82M |
| Net Income | -2.34B | -785.63M | 966.69M | 1.21B | -1.85B |
Balance Sheet | |||||
| Total Assets | 10.21B | 11.52B | 12.65B | 18.27B | 38.19B |
| Cash, Cash Equivalents and Short-Term Investments | 601.40M | 890.20M | 696.11M | 1.38B | 1.40B |
| Total Debt | 1.79B | 1.77B | 1.92B | 4.52B | 12.18B |
| Total Liabilities | 9.82B | 9.02B | 10.11B | 15.88B | 38.90B |
| Stockholders Equity | -1.26B | 1.03B | 1.46B | -462.08M | -1.84B |
Cash Flow | |||||
| Free Cash Flow | -48.21M | -138.10M | -115.49M | -535.80M | 581.72M |
| Operating Cash Flow | -31.02M | -126.82M | -107.99M | -528.72M | 588.26M |
| Investing Cash Flow | -176.83M | -124.68M | -158.34M | -20.22M | -5.32M |
| Financing Cash Flow | -79.82M | 442.45M | 316.98M | -58.62M | -737.61M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
54 Neutral | HK$834.91M | 0.05 | 260.87% | ― | 82.96% | ― | |
42 Neutral | HK$160.16M | -0.10 | -34.31% | ― | -63.41% | 77.97% | |
41 Neutral | HK$484.90M | -0.03 | ― | ― | -64.27% | -19.76% | |
40 Underperform | HK$60.91M | -0.41 | 60.36% | ― | -37.97% | 87.04% | |
39 Underperform | HK$359.42M | -0.66 | -21.15% | ― | 69.55% | 64.09% | |
39 Underperform | HK$180.13M | -0.04 | 93.94% | ― | -60.50% | -103.48% |